Waldenström's macroglobulinemia risk factors: Difference between revisions
Line 9: | Line 9: | ||
Following are the common risk factors associated with waldenström's macroglobulinemia: | Following are the common risk factors associated with waldenström's macroglobulinemia: | ||
'''Monoclonal gammopathy of undetermined significance''': Pre-existing monoclonal gammopathy of undetermined significance is the most common risk factor for the development of waldenström's macroglobulinemia.<ref name="RF">Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015</ref> | '''Monoclonal gammopathy of undetermined significance''': Pre-existing [[monoclonal gammopathy of undetermined significance]] is the most common risk factor for the development of waldenström's macroglobulinemia.<ref name="RF">Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015</ref> | ||
'''Heredity''': Patients with waldenström's macroglobulinemia has a close relative with the disease or with a related B-cell disease, such as MGUS or certain types of lymphoma or leukemia. | '''Heredity''': Patients with waldenström's macroglobulinemia has a close relative with the disease or with a related B-cell disease, such as MGUS or certain types of [[lymphoma]] or [[leukemia]]. | ||
'''Hepatitis C''': Patients with chronic hepatitis C infection are more likely to develop waldenström's macroglobulinemia than general population. | '''Hepatitis C''': Patients with chronic [[hepatitis C]] infection are more likely to develop waldenström's macroglobulinemia than general population. | ||
'''Immune Diseases:''' Autoimmune diseases, such as sjögren syndrome, increase the risk of developing waldenström's macroglobulinemia. | '''Immune Diseases:''' Autoimmune diseases, such as [[sjögren syndrome]], increase the risk of developing waldenström's macroglobulinemia. | ||
==References== | ==References== |
Revision as of 06:55, 5 January 2016
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia risk factors On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia risk factors |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Common risk factors in the development of waldenström's macroglobulinemia are monoclonal gammopathy of undetermined significance, hereditary, hepatitis C, and immune disorders.[1]
Risk Factors
Following are the common risk factors associated with waldenström's macroglobulinemia:
Monoclonal gammopathy of undetermined significance: Pre-existing monoclonal gammopathy of undetermined significance is the most common risk factor for the development of waldenström's macroglobulinemia.[1]
Heredity: Patients with waldenström's macroglobulinemia has a close relative with the disease or with a related B-cell disease, such as MGUS or certain types of lymphoma or leukemia.
Hepatitis C: Patients with chronic hepatitis C infection are more likely to develop waldenström's macroglobulinemia than general population.
Immune Diseases: Autoimmune diseases, such as sjögren syndrome, increase the risk of developing waldenström's macroglobulinemia.
References
- ↑ 1.0 1.1 Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015